Dysmenorrhoea
Conditions
Interventions
The oral administration twice a day for 21 days. This cycle is repeated four times.
Sponsors
Tottori University Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Patients with diagnosis of primary or secondary dysmenorrhea. 2. The menstrual cycle is 28 plus or minus 3 days. 3. The total number of the dysmenorrhea score is three points or more at the time of registering.
Exclusion criteria
Exclusion criteria: 1. Patients with medical history of serious liver failure or liver disease. 2. Patients with medical history of heart disease or kidney disease 3. Patients with porphyria. 4. Patients with medical history of peptic ulceration. 5. Patients with severe abnormal clinical examination. 6. Patients with asthma bronchial or asthma aspirin-sensitive. 7. Patients with colitis ulcerative or Crohn's disease. 8. Treatment with luteal hormone or follicular hormone-based hormone agents, low dose pill, middle dose pill, GnRH agonist, testosterone derivative, follicular hormone antagonist, aromatase inhibitor, Chinese herbal medicine for dysmenorrhea or within 2 months of initiation of administration 9. Treatment with transvaginal alcohol fixative, surgical therapy by laparotomy or laparoscope within 2 months of initiation of administration.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Valuation of total dysmenorrhea score. | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS of pain by dysmenorrhea, dysmenorrhea score, objective, adverse experience | — |
Countries
Japan
Contacts
Public ContactFuminori Taniguchi
Tottori University Hospital Division of Reproductive-Perinatal Medicine and Gynecologic Oncology
Outcome results
None listed